Showing results (1061-1070 of 1,823) with videos related to
Sort By:
Pageof 183
Transplantation and Cellular Therapy|September 21, 2025
Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative StudyMarie-Michèle Sainvil, Ashley L Artese, Laura J Fish, et al.Transplantation and Cellular Therapy|September 19, 2025
Placental-Derived Products for Corneal Regeneration: Applications of Amniotic Membrane, Cord Blood Serum, and Stem Cells: A ReviewSeyed-Hashem Daryabari, Melina Ghasemian, Ehsan Lotfi, et al.Transplantation and Cellular Therapy|September 19, 2025
Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed/Refractory Multiple Myeloma: Real-World Experience from the US Myeloma Immunotherapy ConsortiumKaren Sweiss, Charlotte Wagner, Eric Anto, et al.Transplantation and Cellular Therapy|October 11, 2025
Under the Hood: Evidence-Based Review of Allogeneic Chimeric Antigen Receptor T Cells for Hematologic MalignanciesAsfand Yar Cheema, Hossam M Ali, Bibi Maryam, et al.Transplantation and Cellular Therapy|August 3, 2025
Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR AnalysisKalyan V Nadiminti, Kwang W Ahn, Jinalben Patel, et al.Transplantation and Cellular Therapy|August 3, 2025
NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World StudyXiaolin Yuan, Lihong Ni, Ting Chen, et al.Transplantation and Cellular Therapy|August 1, 2025
CD20CAR-T Therapy Preemptively Treats Patients with Relapsed/Refractory DLBCL in Partial Remission after CD19CAR-TFei Xue, Huazhou Shi, Rui Liu, et al.Transplantation and Cellular Therapy|March 23, 2025
Comparative Efficacy of Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion Before Chimeric Antigen Receptor T-Cell Therapy in LymphomaUttam K Rao, Navneet S Majhail, Betsy Blunk, et al.Transplantation and Cellular Therapy|December 26, 2022
Impact of Conditioning Regimen and Graft-versus-Host Disease Prophylaxis on The Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation for High-Risk Severe Aplastic Anemia in Children and Young Adults: A Report from the Pediatric Severe Aplastic Anemia Consortium of IndiaGaurav Kharya, Sarita R Jaiswal, Sunil Bhat, et al.Transplantation and Cellular Therapy|January 22, 2023
Daratumumab, pomalidomide, and dexamethasone (DPd) followed by high dose chemotherapy-Autologous Stem Cell Transplantation leads to superior outcomes when compared to DPd-alone for patients with Relapsed Refractory Multiple MyelomaHamza Hashmi, Shebli Atrash, Jayanshu Jain, et al.Pageof 183